Faculty of Clinical Sciences, College of Health Sciences, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Surgeons OverSeas, New York, New York.
Cancer. 2018 Jul 1;124(13):2766-2773. doi: 10.1002/cncr.31399. Epub 2018 Apr 12.
Colorectal cancer (CRC) rates in low-resource countries, which typically lack CRC screening programs, are rising. This study determined whether a risk model for patients with rectal bleeding could identify patients with curable CRC.
This prospective, cross-sectional study evaluated a model constructed from data from 1 hospital and validated at 2 other hospitals. The primary endpoint was the ability of the model to predict CRC, as diagnosed by colonoscopy, from clinical characteristics. The secondary endpoint was to determine the percentage of patients who had CRC.
Consecutive patients who were 45 years old or older and had self-reported rectal bleeding for more than 1 week were evaluated. From January 2014 to July 2016, 362 patients answered a questionnaire and underwent colonoscopy. In the validation cohort, 56% of patients with rectal bleeding, weight loss, and changes in bowel habits had CRC, whereas 2% of patients with bleeding alone did. Overall, 18.2% of the patients had CRC, and 8.6% had adenomas. The proportion of CRC patients with potentially curable stage II or III disease was 74%, whereas the historical rate was 36%. The combination of rectal bleeding with both symptoms significantly predicted CRC in the validation set (odds ratio, 12.8; 95% confidence interval, 4.6-35.4; P < .001).
In low-resource settings, patients with rectal bleeding, weight loss, and changes in bowel habits should be classified as high risk for CRC. Patients with a high risk score should be prioritized for colonoscopy to increase the number of patients diagnosed with potentially curable CRC. Cancer 2018;124:2766-2773. © 2018 American Cancer Society.
在资源匮乏国家,结直肠癌(CRC)发病率正在上升,这些国家通常缺乏 CRC 筛查计划。本研究旨在确定一种用于直肠出血患者的风险模型是否能够识别出可治愈 CRC 的患者。
这是一项前瞻性、横断面研究,评估了来自 1 家医院的数据构建的模型,并在另外 2 家医院进行了验证。主要终点是该模型通过临床特征预测由结肠镜检查诊断为 CRC 的能力。次要终点是确定患有 CRC 的患者比例。
从 2014 年 1 月至 2016 年 7 月,连续评估了 362 名年龄在 45 岁及以上、自述直肠出血超过 1 周的患者。在验证队列中,56%有直肠出血、体重减轻和排便习惯改变的患者患有 CRC,而仅出血的患者为 2%。总体而言,18.2%的患者患有 CRC,8.6%的患者患有腺瘤。有潜在可治愈 II 期或 III 期疾病的 CRC 患者比例为 74%,而历史比例为 36%。在验证组中,直肠出血与其他两种症状相结合可显著预测 CRC(比值比,12.8;95%置信区间,4.6-35.4;P<0.001)。
在资源匮乏的环境中,直肠出血、体重减轻和排便习惯改变的患者应被归类为 CRC 的高风险人群。高风险评分的患者应优先进行结肠镜检查,以增加诊断出潜在可治愈 CRC 的患者数量。癌症 2018;124:2766-2773. © 2018 美国癌症协会。